The global biomarker clinical phase outsourcing services market is anticipated to grow at a considerable CAGR of 21.3% during the forecast period (2023-2030). The increasing utilization of biomarkers for several chronic diseases has significantly propelled the market growth. The diverse range of biomarkers and their applications in monitoring and diagnosing several disorders....

The global biomarker clinical phase outsourcing services market is anticipated to grow at a considerable CAGR of 21.3% during the forecast period. The increasing utilization of biomarkers for several chronic diseases has significantly propelled the market growth. The diverse range of biomarkers and their applications in monitoring and diagnosing several disorders. Advancements in biomarker...